Chemoinformaics analysis of Schizonepetoside B
| Molecular Weight | 330.377 | nRot | 2 |
| Heavy Atom Molecular Weight | 304.169 | nRig | 18 |
| Exact Molecular Weight | 330.168 | nRing | 3 |
| Solubility: LogS | -0.996 | nHRing | 2 |
| Solubility: LogP | -0.252 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 7 | APOL | 49.6706 |
| nHD | 3 | BPOL | 32.1594 |
| QED | 0.633 |
| Synth | 4.613 |
| Natural Product Likeliness | 2.682 |
| NR-PPAR-gamma | 0.024 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.065 |
| HIA | 0.711 |
| CACO-2 | -4.999 |
| MDCK | 0.000233392 |
| BBB | 0.259 |
| PPB | 0.203231 |
| VDSS | 0.626 |
| FU | 0.638427 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.295 |
| CYP2c19-inh | 0.009 |
| CYP2c19-sub | 0.449 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.119 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.182 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.114 |
| CL | 3.953 |
| T12 | 0.39 |
| hERG | 0.017 |
| Ames | 0.349 |
| ROA | 0.84 |
| SkinSen | 0.06 |
| Carcinogencity | 0.272 |
| EI | 0.01 |
| Respiratory | 0.046 |
| NR-Aromatase | 0.037 |
| Antiviral | Yes |
| Prediction | 0.862336 |